Notice of Intent to Sole Source - Bioinformatics Services

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Georgia Tech Research Corporation to extend the development of the bioinformatics pipeline for genotyping of human papillomavirus including calling new and known HPV variants and identification of HPV integration status. Georgia Tech Research Corporation has unique expertise in genome analysis and genome annotation and proprietary GeneMark software. It has developed the proprietary software tools used in pioneering genome projects and developing custom-built pipelines for genome annotation in which their original algorithms play a central role. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at rju8@cdc.gov by COB 12 August 2022.